94 related articles for article (PubMed ID: 6243152)
1. Neonatal susceptibility to MHV3 infection in mice. II. Role of natural effector marrow cells in transfer of resistance.
Tardieu M; Héry C; Dupuy JM
J Immunol; 1980 Jan; 124(1):418-23. PubMed ID: 6243152
[TBL] [Abstract][Full Text] [Related]
2. Neonatal susceptibility to MHV3 infection in mice. I. Transfer of resistance.
Levy-Leblond E; Dupuy JM
J Immunol; 1977 Apr; 118(4):1219-22. PubMed ID: 300403
[TBL] [Abstract][Full Text] [Related]
3. Genetically determined resistance to mouse hepatitis virus 3 is expressed in hematopoietic donor cells in radiation chimeras.
Dupuy JM; Dupuy C; Décarie D
J Immunol; 1984 Sep; 133(3):1609-13. PubMed ID: 6146650
[TBL] [Abstract][Full Text] [Related]
4. Mouse hepatitis virus 3 replication in T and B lymphocytes correlate with viral pathogenicity.
Lamontagne L; Descoteaux JP; Jolicoeur P
J Immunol; 1989 Jun; 142(12):4458-65. PubMed ID: 2542412
[TBL] [Abstract][Full Text] [Related]
5. Resistance of naive mice to murine hepatitis virus strain 3 requires development of a Th1, but not a Th2, response, whereas pre-existing antibody partially protects against primary infection.
Pope M; Chung SW; Mosmann T; Leibowitz JL; Gorczynski RM; Levy GA
J Immunol; 1996 May; 156(9):3342-9. PubMed ID: 8617959
[TBL] [Abstract][Full Text] [Related]
6. Genetically determined resistance to foreign bone marrow transplantation in mice: characterization of the effector cells.
Miller SC
J Immunol; 1983 Jul; 131(1):92-7. PubMed ID: 6345669
[TBL] [Abstract][Full Text] [Related]
7. Mouse hepatitis virus 3 pathogenicity expressed by a lytic viral infection in bone marrow 14.8+ mu+ B lymphocyte subpopulations.
Jolicoeur P; Lamontagne L
J Immunol; 1989 Dec; 143(11):3722-30. PubMed ID: 2555417
[TBL] [Abstract][Full Text] [Related]
8. Use of adoptive transfer and Winn assay procedures in the further analysis of antiviral acquired immunity in mice protected against Friend leukemia virus-induced disease by passive serum therapy.
Genovesi EV; Pettey CL; Collins JJ
Cancer Res; 1984 Apr; 44(4):1489-98. PubMed ID: 6608407
[TBL] [Abstract][Full Text] [Related]
9. Impaired T and B cell subpopulations involved in a chronic disease induced by mouse hepatitis virus type 3.
Jolicoeur P; Lamontagne L
J Immunol; 1994 Aug; 153(3):1318-7. PubMed ID: 8027559
[TBL] [Abstract][Full Text] [Related]
10. Resistance to fatal central nervous system disease by mouse hepatitis virus, strain JHM. II. Adherent cell-mediated protection.
Stohlman SA; Frelinger JA; Weiner LP
J Immunol; 1980 Apr; 124(4):1733-9. PubMed ID: 6245128
[TBL] [Abstract][Full Text] [Related]
11. Resistance of genetically selected mice to MHV3 infection is not dependent on the H2O2 release by macrophages.
Vassão R; Russo M; Marcondes MC; Pereira CA
Microb Pathog; 1993 Mar; 14(3):169-76. PubMed ID: 8391622
[TBL] [Abstract][Full Text] [Related]
12. Bone marrow cell-dependency of delayed-type hypersensitivity response in mice infected with mouse hepatitis virus.
Kyuwa S; Yamaguchi K; Fujiwara K; Yamanouchi K
Jpn J Exp Med; 1986 Jun; 56(3):93-8. PubMed ID: 3020283
[TBL] [Abstract][Full Text] [Related]
13. Determinants of susceptibility and resistance to feline leukemia virus infection. II. Susceptibility of feline lymphocytes to productive feline leukemia virus infection.
Rojko JL; Hoover EA; Finn BL; Olsen RG
J Natl Cancer Inst; 1981 Oct; 67(4):899-910. PubMed ID: 6268886
[TBL] [Abstract][Full Text] [Related]
14. [Analysis of antigen-specific proliferation and IL-2/IL-4 production of spleen cells from mice infected with Mycobacterium bovis BCG].
Teruya K; Kawakami K; Tohyama M; Saito A
Kekkaku; 1995 Apr; 70(4):293-9. PubMed ID: 7760538
[TBL] [Abstract][Full Text] [Related]
15. B lymphocyte lineage cells in newborn and very young NZB mice: evidence for regulatory disorders affecting B cell formation.
Jyonouchi H; Kincade PW; Good RA; Gershwin ME
J Immunol; 1983 Nov; 131(5):2219-25. PubMed ID: 6605377
[TBL] [Abstract][Full Text] [Related]
16. [Frontier of mycobacterium research--host vs. mycobacterium].
Okada M; Shirakawa T
Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
[TBL] [Abstract][Full Text] [Related]
17. Tumor growth inhibitory and natural suppressor activities of murine bone marrow cells: a comparative study.
Seledtsov VI; Taraban VY; Seledtsova GV; Samarin DM; Avdeev IV; Senyukov VV; Kozlov VA
Cell Immunol; 1997 Nov; 182(1):12-9. PubMed ID: 9427805
[TBL] [Abstract][Full Text] [Related]
18. Immunodepression of lymphocyte response in mouse hepatitis virus 3 infection.
Krzystyniak K; Dupuy JM
Biomed Pharmacother; 1983; 37(2):68-74. PubMed ID: 6311308
[TBL] [Abstract][Full Text] [Related]
19. Life history of cells mediating natural resistance to tumor cells and bone-marrow transplants: the respective roles of cell lineage commitment and host environment in determining strain characteristics of natural resistance to foreign marrow grafts.
Miller SC
Am J Anat; 1984 Jul; 170(3):367-76. PubMed ID: 6383004
[TBL] [Abstract][Full Text] [Related]
20. [Response of splenic lymphocytes to phytohemagglutinin and bacterial lipopolysaccharide in mice, sensitive and resistant to mouse hepatitis virus 3 (MHV3)].
Grollemund E; Obert G; Nonnenmacher H; Kirn A
C R Seances Acad Sci III; 1981 Feb; 292(8):533-6. PubMed ID: 6261984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
